Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2025-05-20 Capital/Financing Update
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2025
Capital/Financing Update Classification · 1% confidence The document is a 'Company Announcement' from Genmab A/S detailing a 'Capital Increase in Genmab as a Result of Employee Warrant Exercise'. This announcement explicitly states the number of shares issued, the subscription prices, the resulting capital increase, and the new total share capital. This content directly relates to changes in the company's capital structure and share count, fitting the definition of 'Capital/Financing Update' (CAP). Although it involves shares, it is not a general share repurchase (POS) but a specific capital increase event. It is not a full report (10-K, IR) nor a dividend notice (DIV). The presence of an 'Attachment' suggests it might be an RPA, but the core content is the capital change itself, making CAP the most specific fit for the substance of the announcement.
2025-05-20 English
6-K
Foreign Filer Report
2025-05-19 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Transactions in Connection with Share Buy-back Program" and details the number of shares bought back on specific dates (May 12 to May 16, 2025) under an existing program. This activity directly relates to the company managing its own stock, which falls under the category of 'Transaction in Own Shares'. The code for this is POS. The document is a detailed announcement, not just a notice that a report is attached, so RPA/RNS is less appropriate than the specific transaction type.
2025-05-19 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is titled "Transactions in Connection with Share Buy-back Program" and details the number of shares repurchased by Genmab A/S on specific dates (May 12 to May 16, 2025) under an existing program. This activity directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The filing category code for this activity is POS.
2025-05-19 English
Director's Dealing 2025
Director's Dealing Classification · 1% confidence The document text consists almost entirely of tables detailing transactions (Issuer, Date, Time, Quantity, Price, Venue) for GENMAB A/S on a specific date (12-May-2025). This structure strongly indicates a report of insider transactions or director's dealings, as it tracks individual share movements by an entity. Reviewing the definitions: - 10-K/IR: These are comprehensive financial reports, which this is not. - ER/MRQ: These are earnings/quarterly results, which this is not. - DIV/CAP/SHA: These relate to dividends or capital structure changes, not routine trading logs. - DIRS (Director's Dealing): This category covers reports of personal share transactions by company directors and executives (insider trades). The data presented is a log of share transactions, which aligns perfectly with the nature of a Director's Dealing report, even if the specific insider name is not explicitly stated in the truncated text (the context implies regulatory reporting of trades). - POS (Transaction in Own Shares): This is for the company buying back/selling its own shares, whereas this log appears to be market transactions. Given the tabular format detailing specific trade executions (Quantity, Price, Venue) for the issuer, the most appropriate classification is Director's Dealing (DIRS).
2025-05-19 English
6-K
Foreign Filer Report
2025-05-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.